Transjugular Intrahepatic Portosystemic Shunt Placement is Associated with Increased All-Cause and Cardiac Mortality in Those Undergoing Liver Transplant for Nonalcoholic Steatohepatitis
1Department of Gastroenterology and Hepatology, University of Maryland, Baltimore, MD, 2Tufts Medical Center, Boston, MA, 3University of Maryland, Baltimore, MD
Meeting: 2022 American Transplant Congress
Abstract number: 123
Keywords: Graft failure, Outcome, Portal veins, Rejection
Topic: Clinical Science » Liver » 53 - Liver: Cirrhosis - Portal Hypertension and Other Complications
Session Information
Session Name: Cirrhosis: Complications, Portal Hypertension and Renal Management
Session Type: Rapid Fire Oral Abstract
Date: Sunday, June 5, 2022
Session Time: 5:30pm-7:00pm
Presentation Time: 5:40pm-5:50pm
Location: Hynes Room 311
*Purpose: Since the effect of transjugular intrahepatic portosystemic shunt (TIPS) on post LT outcomes is not well understood, we undertook this analysis of a large national transplant registry to assess outcomes in LT recipients with NASH who had undergone pre-LT TIPS.
*Methods: UNOS-STAR registry (2005-2019) was used to identify adult deceased donor LT recipients with diagnosis of nonalcoholic steatohepatitis (NASH/cryptogenic cirrhosis). We compared the following endpoints: all-cause mortality, graft failure, and organ-specific causes of death in those with and without pre-LT TIPS placement. Living/multiorgan transplants were excluded.
*Results: From 14575 LT recipients with NASH, 1700 underwent preoperative TIPS insertion and 12875 did not receive TIPS. The median follow-up period was 3.07 years. Those who underwent TIPS were older, more likely to be male, and more likely to be White or Hispanic. Those who received pre-LT TIPS had higher incidence of hepatic encephalopathy, and lower median MELD scores (22.3 vs 24.2 p<0.001). In the iterative cox regression analysis, preoperative TIPS insertion was associated with higher all-cause mortality (aHR 1.15 95%CI 1.03-1.27), as well as deaths due to general cardiac causes (aHR 1.44 95%CI 1.16-1.80), cardiac arrhythmia (aHR 4.15 95%CI 1.93-8.94), and congestive heart failure (aHR 2.18 95%CI 1.15-4.15). This increase in mortality persisted despite adjusting for recipient demographics, comorbidities, medications, biochemical parameters, and donor information.
*Conclusions: Our analysis of a large national transplant database demonstrates the deleterious effect of pre-LT TIPS on post-LT outcomes in recipients with NASH, attributable to increased all-cause mortality and cardiac events. It is therefore important that careful pre-TIPS cardiac screening and evaluation be undertaken to mitigate these risks prior to LT, particularly in those with NASH.
To cite this abstract in AMA style:
Lee DU, Han J, Kwon J, Chang K, Fan G, Lee K, Urrunaga N, Bhati C, Maluf D, Shetty K. Transjugular Intrahepatic Portosystemic Shunt Placement is Associated with Increased All-Cause and Cardiac Mortality in Those Undergoing Liver Transplant for Nonalcoholic Steatohepatitis [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/transjugular-intrahepatic-portosystemic-shunt-placement-is-associated-with-increased-all-cause-and-cardiac-mortality-in-those-undergoing-liver-transplant-for-nonalcoholic-steatohepatitis/. Accessed November 21, 2024.« Back to 2022 American Transplant Congress